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Abstract. Since quinine does not inhibit the growth of Plasmodium falciparum ring stages or mature schizonts,
parasites may continue to emerge from sequestration sites after starting treatment. We used polymerase chain reaction
amplification of P. falciparum merozoite surface protein 1 (MSP-1) and MSP-2 alleles to distinguish genotypes infecting
58 children with severe malaria. To examine changes in parasite populations in peripheral blood over time, we compared
changes in number and spectrum of genotypes in samples on admission to a hospital to those obtained up to 24 hours
later. Thirty-four children lost genotypes, 21 retained genotypes, and 3 gained an extra P. falciparum genotype at one
locus but not the other. The lack of novel genotypes emerging suggests that among children with severe malaria the
dominant clones sequestered in deep organs are usually the same as those in peripheral circulation.
INTRODUCTION
Immunity to malaria is acquired slowly in the first decade
of life after repeated exposure to Plasmodium falciparum,
and young children have the greatest burden of severe dis-
ease. Individuals are usually infected with mixtures of geno-
types1 as a result of sexual reproduction that generates new
genotypes2,3 and novel alleles by intragenic recombination.4
Malaria infections are composed of a variable number of
distinct genotypes, with a mean of 2–3 genotypes in one pa-
tient sample. In Malawian pregnant women, we have shown
that the genotypes present in peripheral blood were fre-
quently different from those in placental blood, suggesting
that some genotypes were circulating in the peripheral blood
while others were sequestered in the tissues.5 We hypoth-
esized that parasites circulating in peripheral blood in chil-
dren with severe and complicated malaria are genetically dis-
tinct from those sequestered in the brain and other organs,
and that a proportion of parasites sequestered on admission
would emerge into the peripheral blood over an 18–24-hour
period post-admission. Data from longitudinal studies in
asymptomatic children indicate that such a process occurs in
children with asymptomatic malaria infections, with varia-
tions in the P. falciparum population in blood samples col-
lected on a daily or third-day basis.6,7
Among individuals treated with parenteral quinine, para-
site clearance time is frequently greater than 24 hours.8 If
sequestered and circulating parasites are genetically distinct
broods, as has been described in asymptomatic infection,7 one
might expect to find new genotypes emerging in peripheral
blood of children under quinine treatment, as a result of con-
tinuing schizogony among sequestered parasites and invasion
of more erythrocytes by merozoites.
We used a nested polymerase chain reaction (PCR) to am-
plify genes encoding merozoite surface protein 1 (MSP-1) and
MSP-2 to distinguish different genotypes in admission
samples and at 18 and/or 24 hours. This method provides the
advantage of great sensitivity and specificity, and distin-
guishes between alleles of similar serologic properties by size
polymorphism.9 We asked whether parasites persisting at 18–
24 hours after admission had different genotypes to those
present on admission, which might indicate different broods
of parasites in the periphery and in the tissues.
MATERIALS AND METHODS
Patient selection and blood sampling. Children admitted to
the pediatric ward of the Queen Elizabeth Central Hospital in
Blantyre, Malawi between January 2002 and July 2003 with
suspected severe and complicated malaria10 and parasitemia
 1% on thin blood film examination were recruited for the
study. After consent was obtained from a child’s parent or
guardian, clinical histories were recorded and the patients
were treated with parenteral quinine (20 mg/kg loading dose,
10 mg/kg twice a day). Finger prick blood samples were col-
lected every six hours. Malaria parasitemia was quantitated
using Giemsa-stained thick and thin blood films, and 200 L
of whole blood was collected into EDTA-containing micro-
tainers for DNA extraction. Samples with microscopically de-
tectable parasitemia at 18 and/or 24 hours were chosen for
DNA extraction. All samples were frozen at −20°C until ex-
traction of DNA was performed.
PCR analysis. DNA extraction was performed using the
QIAamp DNA Mini Kit (Qiagen, Crawley, United King-
dom). DNA was eluted in 200 L of 10 mM Tris-HCl, 0.5 mM
EDTA, pH 9.0, and frozen at −20°C. Samples were genotyped
by a nested PCR using primer pairs specific for amplifying the
known allelic families of MSP-1 and MSP-2.11 The targeted
polymorphic regions of MSP-1 and MSP-2 were amplified in
a primary PCR using 1 L of template DNA on a PTC-200
thermal cycler (MJ Research Inc., Watertown, MA) under
the following conditions: 94°C for 5 minutes, 25 cycles at 94°C
for 1 minute, 58°C for 2 minutes, and 72°C for 1 minute, and
a final extension at 72°C for 2 minutes. All reactions were
conducted in a volume of 20 L and contained 125 M
dNTPs, 125 nM oligonucleotides, and 0.5 units of Taq poly-
merase. Two microliters of primary product was used to ini-
tiate a secondary reaction with specific nested oligonucleotide
pairs targeting each of the allelic families of MSP-1 and MSP-
2. This reaction used 30 cycles as above with an annealing
temperature of 61°C. Positive and negative controls were in-
cluded in all batches.
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All products were analyzed by electrophoresis in 2% aga-
rose gels (0.5 × Tris-borate-EDTA buffer), stained with ethid-
ium bromide, and visualized by ultraviolet transillumination.
Each patient’s matched samples were run in adjacent wells in
all assays. The number of bands visualized within expected
size ranges11 were counted for each allelic family and
summed. The minimum number of genotypes was specified as
the highest total number of bands within either the MSP-1 or
MSP-2 allelic families.6 All samples that resulted in different
bands at 18 or 24 hours from admission samples were retested
for confirmation.
Ethical approval. This study was reviewed and approved by
the College of Medicine Research and Ethics Committee,
University of Malawi.
RESULTS
During the study period, 295 children with severe and com-
plicated malaria were admitted to the pediatric ward of
Queen Elizabeth Central Hospital and 58 children with par-
asitemia  1% completed the study. Reasons for non-
completion included low initial parasitemia, early clearance
of parasitemia (before 18 hours), and death of the patient.
Twenty-eight children had cerebral malaria alone, 19 had ce-
rebral malaria combined with severe anemia (hematocrit
< 15%), 5 had severe anemia, and 6 had non-severe malaria
with or without prostration. Logistic difficulties prevented ex-
amination of samples from children who were aparasitemic by
microscopy by 18 hours. DNA was extracted and PCR was
performed at 0, 18, and 24 hours in 33 patients, at 0 and 24
hours in 18 patients, and 0 and 18 hours in 7 patients. Parasite
genotypes studied by PCR amplification of three MSP-1 and
two MSP-2 alleles showed a mean of 2–3 genotypes per pa-
tient (Table 1).
Comparing the number of genotypes at 0, 18, and 24 hours,
we found that 3 patient isolates gained extra genotypes at
either MSP-1 or MSP-2 2 loci, 13 patient isolates lost geno-
types at either MSP-1 or MSP-2, 21 patient isolates lost geno-
types at both MSP-1 and MSP-2, and 21 patient isolates re-
tained all their genotypes throughout the 24-hour period
(Table 2).
The single isolate that gained genotypes at the MSP-1 locus
gained one genotype at the 24-hour time point in addition to
an existing genotype for RO33 and gained two new genotypes
for K1. For the two isolates that gained genotypes at the
MSP-2 locus only, one isolate gained a new genotype for IC at
the 24-hour point (this had no existing genotype for IC) and
another isolate gained one FC27 genotype in addition to an
existing genotype. No patient gained genotypes at both loci.
There was no association between clinical diagnosis and pat-
terns of change in genotype. Children who died or had se-
quelae did not have more genotypes on admission than those
making a full recovery (median  3, range  1–8 compared
with median 3, range  1–6), but they tended to be more
likely to lose genotypes over admission (11 of 34, 32% com-
pared with 2 of 23, 9%; P  0.054, by Fisher’s exact test).
Outcome was missing on one patient.
DISCUSSION
Our principal hypothesis was that novel parasite genotypes
may emerge into the peripheral blood over the first 24 hours
after admission with severe malaria. This phenomenon might
be a consequence of differential emergence of different geno-
types after schizont rupture. This appears to be the case in
asymptomatic malaria,6,7 but not in symptomatic infection.12
We found no compelling evidence for this in severe disease.
Instead, many samples showed a loss of genotypes, consistent
with parasite densities decreasing below detection threshold
after initiation of therapy (as expected), and a large propor-
tion of patients retained their genotypes over 24 hours despite
quinine treatment. Although clearance of parasite DNA from
the circulation may be delayed for 24 hours,13 and persistent
DNA may contribute to our genotype findings, we believe
viable parasites are a more likely explanation. All patients
had detectable parasitemia by microscopy at each sampling
point, and persistence of microscopically identifiable ring-
stage parasites in peripheral blood well beyond 24 hours was
common. In Thai adults, the median time to clearance of
parasitemia on quinine treatment was 64 hours.8 Persistent
genotypes could also be due to gametocytes, which frequently
are of mixed genotypes;14 we cannot exclude this as a con-
tributing factor.
Rings normally grow to mature trophozoite stage by 18
hours post-invasion, when they disappear from peripheral
blood and sequester in tissues. If quinine retarded parasite
maturation, rings might persist for 24 hours after starting
treatment. However, they appear to be resistant to quinine,15
except in the presence of high concentrations that would not
be attained within the first 24 hours of treatment,16 making
this explanation less likely.
There is some evidence that sequestration and schizogony
continue for more than 24 hours after initial administration of
quinine treatment,8 and also that quinine does not signifi-
cantly reduce cytoadherence.17 Thus, repopulation of periph-
eral blood with progeny of sequestered parasites may con-
TABLE 1
Average number of genotypes and distribution of merozoite surface
protein 1 (MSP 1) and MSP2 alleles relative to time from admission








MSP 1 MSP 2
MAD20 KI RO33 FC27 IC
0 3.0; 3.0; (1–8) 81% 53% 62% 64% 90%
18 2.2; 2.0; (0–6) 73% 46% 46% 49% 89%
24 2.1; 2.0; (0–5) 76% 33% 41% 59% 84%
* Values are the mean; median; (range).
TABLE 2
Number of Malawian children with severe and complicated malaria








MSP 1 only 1 (1.7) 9 (15.5) †
MSP 2 only 2 (3.4) 4 (6.9) †
MSP 1 and MSP 2 0 (0) 21 (36.2) 21 (36.2)
Total 3 (5.2) 34 (58.6) 21 (36.2)
* MSP 1  merozoite surface protein 1.
† All patients who lost MSP 1 genotypes retained their MSP 2 genotypes and those who
lost MSP 2 genotypes retained their MSP 1 genotypes. No patient gained genotypes at both
loci.
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tinue after starting therapy. Our data suggest such repopula-
tion is composed of parasites of the same dominant genotypes
as those circulating at admission.
Changes in genotypes at one locus only could be attributed
to technical problems. Our nested PCR might have failed to
amplify MSP-1 or MSP-2 alleles present at levels below the
threshold of sensitivity. Our results show that of 58 patients
studied, only 3 (5.2%) had new genotypes detected at either
the MSP-1 or MSP-2 loci. If two strains were identical at one
locus, a new genotype may show only one new band. Apart
from our favored explanation, that sequestered parasites are
re-emerging into the circulation, other possible explanations
for detection of a single new band also include variations in
the quality of DNA or performance of PCR, and competition
between different genotypes in our PCRs. By extracting
matched samples at the same time, by repeating assays with
potential new genotypes, and by running matched samples in
adjacent wells in the same assay, we believe we have mini-
mized potential artifacts as the cause of our findings.
Malaria syndrome did not appear to influence the degree of
change in genotype seen, although we had relatively few
samples from children with severe anemia or uncomplicated
malaria. The surprising finding that the proportion of isolates
showing genotype loss tended to be higher in children with
unfavorable outcomes was not explained either by differences
in numbers of genotype on admission, or by differences in
proportions of isolates tested at 18 compared with 24 hours,
and may warrant further investigation.
The results suggest that dominant clones persist in both
circulating parasites and those sequestered in the tissues.
These observations confirm and extend those of Missinou and
others.12 In Gabon, children with single episodes of P. falci-
parum malaria were found to carry parasites with the same
genotypes throughout the course of infection.12 The observa-
tions of genetically distinct, asynchronous broods of parasites
in asymptomatic infection6,7 do not appear to be relevant to
severe malaria pathogenesis, but suggest instead that rela-
tively uniform dominant populations of genotypes may be
found in both peripheral blood and tissues. Detailed compari-
son of peripheral blood and tissues from autopsy studies of
children with fatal malaria will resolve this question.
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